Results 11 to 20 of about 122 (92)

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy. [PDF]

open access: yesBr J Haematol
Three‐year overall survival (OS) and leukaemia‐free survival (LFS) rates were 28.5% and 24.4% in allogeneic haematopoietic cell transplantation (HCT) for primary refractory acute myeloid leukaemia from 2013 to 2022 in Japan. Age ≥ 50 years, performance status ≥2, adverse cytogenetics, extramedullary disease at diagnosis and peripheral blood blasts at ...
Konuma T   +22 more
europepmc   +2 more sources

Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study. [PDF]

open access: yesCancer Sci, 2020
The survival curve shows that the prognoses of patients with acute and lymphoma‐type ATL in Japan have improved modestly, but those of patients with chronic and smoldering‐type ATL have not improved. Abstract Adult T‐cell leukemia/lymphoma (ATL) is a mature T‐cell neoplasm and is classified into four subtypes (acute, lymphoma, chronic, and smoldering ...
Imaizumi Y   +17 more
europepmc   +2 more sources

Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice. [PDF]

open access: yesPhysiol Rep
Abstract Chronic kidney disease is a life‐threatening disease worldwide. PPARα is a crucial transcriptional regulator of lipid metabolism and inflammation. Here, we examine whether a novel selective PPARα modulator, pemafibrate modulates renal injury in a model of unilateral ureteral obstruction (UUO).
Takahara K   +11 more
europepmc   +2 more sources

Reviewer summary for Acute Medicine & Surgery [PDF]

open access: yesAcute Med Surg, 2023
Acute Medicine &Surgery, Volume 10, Issue 1, January/December 2023.
europepmc   +2 more sources

Reviewers acknowledgement [PDF]

open access: yesMol Oncol, 2021
Molecular Oncology, Volume 15, Issue 1, Page 318-323, January 2021.
europepmc   +2 more sources

Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey. [PDF]

open access: yesCancer Sci, 2017
A multicenter, hospital‐based survey of newly diagnosed ATL patients from 2010 to 2011 was conducted.This survey clarified that half of current patients with ATL were aged over 68 years. Adult T‐cell leukemia–lymphoma (ATL) is a mature T‐cell malignancy associated with human T‐cell leukemia virus type 1 (HTLV‐1) infection.
Nosaka K   +17 more
europepmc   +2 more sources

Reviewers [PDF]

open access: yesCancer Sci
Cancer Science, Volume 117, Issue 1, Page 275-279, January 2026.
europepmc   +2 more sources

AMS Reviewer Summary 2024 [PDF]

open access: yesAcute Med Surg
Acute Medicine &Surgery, Volume 12, Issue 1, January/December 2025.
europepmc   +2 more sources

Reviewer Summary for Acute Medicine & Surgery [PDF]

open access: yesAcute Med Surg
Acute Medicine &Surgery, Volume 11, Issue 1, January/December 2024.
europepmc   +2 more sources

Abstracts [PDF]

open access: yesCancer Sci, 2023
Cancer Science, Volume 114, Issue S1, Page 1-2317, February 2023.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy